Beating Cancer With Lance Armstrong

Testicular cancer is the most common type of cancer in young men. As many as 8,000 men are diagnosed in the U.S. each year with the disease. But thanks to Dr. Lawrence Einhorn of the Indiana University School of Medicine, what was once a death sentence is now one of the most treatable forms of cancer.

One of the many thankful men alive today is seven-time Tour De France champion cyclist, Lance Armstrong.

In 1996, Armstrong was diagnosed with an aggressive form of testicular cancer and sought out none other than Dr. Einhorn for treatment. It was Dr. Einhorn’s revolutionary chemotherapy regimen that ultimately cured Armstrong.

Einhorn's most accredited medical contribution is his work in the mid-1970s developing the groundbreaking chemotherapy regimen which dramatically increased the rate of survival for testicular cancer patients like Armstrong. Because of this remarkable work, the survival rate for patients with testicular cancer is now approximately 95 percent.

In 2005, the Lance Armstrong Foundation honored Einhorn and Indiana University by establishing the Lance Armstrong Foundation Chair in Oncology at IU. The $1.5 million endowment, chaired by Einhorn, continues to provide funding for research and clinical studies.